Literature DB >> 18417029

Oral manifestations associated with HIV infection.

Mostafa Nokta1.   

Abstract

Oral lesions are among the early signs of HIV infection and can predict progression to AIDS. The lesions commonly associated with the infection include oral candidiasis, herpes simplex infection, oral Kaposi's sarcoma, oral hairy leukoplakia, parotid gland enlargement, gingival diseases, xerostomia, and recurrent oral ulcerations. The introduction of highly active antiretroviral therapy has changed the epidemiology of some of the oral diseases associated with HIV infection. This review discusses the oral manifestations associated with HIV disease, the change in the pattern of the disease, and some research questions that need more emphasis from the research community.

Entities:  

Mesh:

Year:  2008        PMID: 18417029     DOI: 10.1007/s11904-008-0002-8

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  77 in total

Review 1.  1999 International International Workshop for a Classification of Periodontal Diseases and Conditions. Papers. Oak Brook, Illinois, October 30-November 2, 1999.

Authors: 
Journal:  Ann Periodontol       Date:  1999-12

2.  Effect of highly active antiretroviral therapy on frequency of oral warts.

Authors:  D Greenspan; A J Canchola; L A MacPhail; B Cheikh; J S Greenspan
Journal:  Lancet       Date:  2001-05-05       Impact factor: 79.321

Review 3.  Herpesviruses in periodontal diseases.

Authors:  Jørgen Slots
Journal:  Periodontol 2000       Date:  2005       Impact factor: 7.589

4.  Meth abuse causes extensive dental decay.

Authors:  Jacqueline Mitchell
Journal:  Todays FDA       Date:  2006-10

5.  Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.

Authors:  J M Jacobson; J S Greenspan; J Spritzler; N Ketter; J L Fahey; J B Jackson; L Fox; M Chernoff; A W Wu; L A MacPhail; G J Vasquez; D A Wohl
Journal:  N Engl J Med       Date:  1997-05-22       Impact factor: 91.245

Review 6.  Clinical aspects and management of AIDS-related Kaposi's sarcoma.

Authors:  A M Levine; A Tulpule
Journal:  Eur J Cancer       Date:  2001-07       Impact factor: 9.162

Review 7.  Acquired immunodeficiency syndrome-related lymphoma in the era of highly active antiretroviral therapy.

Authors:  Christina Thirlwell; Debashis Sarker; Justin Stebbing; Mark Bower
Journal:  Clin Lymphoma       Date:  2003-09

8.  Cross-clade HIV-1-specific neutralizing IgA in mucosal and systemic compartments of HIV-1-exposed, persistently seronegative subjects.

Authors:  Claudia Devito; Jorma Hinkula; Rupert Kaul; Joshua Kimani; Peter Kiama; Lucia Lopalco; Claudia Barass; Stefania Piconi; Daria Trabattoni; Job J Bwayo; Francis Plummer; Mario Clerici; Kristina Broliden
Journal:  J Acquir Immune Defic Syndr       Date:  2002-08-01       Impact factor: 3.731

9.  Unusual oral presentation of non-Hodgkin's lymphoma in association with HIV infection.

Authors:  C L Dodd; D Greenspan; M Schiødt; T E Daniels; J H Beckstead; L A MacPhail; S Miyasaki; J S Greenspan
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1992-05

10.  Association of dental health parameters with oral lesion prevalence in human immunodeficency virus-infected Romanian children.

Authors:  Jung-Wei Chen; Catherine M Flaitz; Blake Wullbrandt; John Sexton
Journal:  Pediatr Dent       Date:  2003 Sep-Oct       Impact factor: 1.874

View more
  26 in total

1.  Oral human β-defensin 2 in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  Wipawee Nittayananta; Marisa Kemapunmanus; Korntip Amornthatree; Sineepat Talungchit; Hutcha Sriplung
Journal:  J Oral Pathol Med       Date:  2012-06-09       Impact factor: 4.253

2.  Oral lesions among HIV-infected children on antiretroviral treatment in West Africa.

Authors:  David Meless; Boubacar Ba; Malick Faye; Jean-Serge Diby; Serge N'zoré; Sébastien Datté; Lucrèce Diecket; Clémentine N'Diaye; Edmond Addi Aka; Kouadio Kouakou; Abou Ba; Didier Koumavi Ekouévi; François Dabis; Caroline Shiboski; Elise Arrivé
Journal:  Trop Med Int Health       Date:  2014-01-06       Impact factor: 2.622

3.  AIDS-related Kaposi's sarcoma.

Authors:  Vincent M Brandenburg; Andreas H Mahnken
Journal:  Wien Klin Wochenschr       Date:  2009       Impact factor: 1.704

4.  Oral hairy leukoplakia: a clinical indicator of immunosuppression.

Authors:  Alexander Kreuter; Ulrike Wieland
Journal:  CMAJ       Date:  2011-03-07       Impact factor: 8.262

5.  Oral hairy leukoplakia which occurred as a presenting sign of acute myeloid leukemia in a child.

Authors:  Hyun-Ho Cho; Su-Han Kim; Sang-Hee Seo; Do-Sang Jung; Hyun-Chang Ko; Moon-Bum Kim; Kyung-Sool Kwon
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

6.  HIV-1 reactivation induced by the periodontal pathogens Fusobacterium nucleatum and Porphyromonas gingivalis involves Toll-like receptor 2 [corrected] and 9 activation in monocytes/macrophages.

Authors:  Octavio A González; Mengtao Li; Jeffrey L Ebersole; Chifu B Huang
Journal:  Clin Vaccine Immunol       Date:  2010-07-07

7.  Effects of long-term use of HAART on oral health status of HIV-infected subjects.

Authors:  Wipawee Nittayananta; Sineepat Talungchit; Sutep Jaruratanasirikul; Kachornsakdi Silpapojakul; Panthip Chayakul; Ampaipith Nilmanat; Nannapat Pruphetkaew
Journal:  J Oral Pathol Med       Date:  2010-02-22       Impact factor: 4.253

8.  Oral hairy leukoplakia in healthy immunocompetent patients: a small case series.

Authors:  Daire Shanahan; Rachel Cowie; Helen Rogers; Konrad Staines
Journal:  Oral Maxillofac Surg       Date:  2018-08-06

9.  Candida albicans adhesion to composite resin materials.

Authors:  Ralf Bürgers; Wulf Schneider-Brachert; Martin Rosentritt; Gerhard Handel; Sebastian Hahnel
Journal:  Clin Oral Investig       Date:  2008-09-23       Impact factor: 3.573

10.  Expression of oral cytokines in HIV-infected subjects with long-term use of antiretroviral therapy.

Authors:  W Nittayananta; K Amornthatree; M Kemapunmanus; S Talungchit; H Sriplung
Journal:  Oral Dis       Date:  2013-05-30       Impact factor: 3.511

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.